PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $2,000 | -50.0% | 300 | -40.0% | 0.00% | -66.7% |
| Q2 2014 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $4,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |